🇯🇵 Aricept in Japan

PMDA authorised Aricept on 23 December 2022

Marketing authorisation

PMDA — authorised 23 December 2022

  • Marketing authorisation holder: Teikoku Seiyaku Co., Ltd.
  • Status: approved

Aricept in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Japan

Frequently asked questions

Is Aricept approved in Japan?

Yes. PMDA authorised it on 23 December 2022.

Who is the marketing authorisation holder for Aricept in Japan?

Teikoku Seiyaku Co., Ltd. holds the Japanese marketing authorisation.